Cargando…
Overview of current targeted therapy in gallbladder cancer
Gallbladder cancer (GBC) is rare, but is the most malignant type of biliary tract tumor. Unfortunately, only a small population of cancer patients is acceptable for the surgical resection, the current effective regimen; thus, the high mortality rate has been static for decades. To substantially circ...
Autores principales: | Song, Xiaoling, Hu, Yunping, Li, Yongsheng, Shao, Rong, Liu, Fatao, Liu, Yingbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542154/ https://www.ncbi.nlm.nih.gov/pubmed/33028805 http://dx.doi.org/10.1038/s41392-020-00324-2 |
Ejemplares similares
-
The PLGF/c‐MYC/miR‐19a axis promotes metastasis and stemness in gallbladder cancer
por: Li, Huaifeng, et al.
Publicado: (2018) -
TASP1 Promotes Gallbladder Cancer Cell Proliferation and Metastasis by Up-regulating FAM49B via PI3K/AKT Pathway
por: Zhang, Yijian, et al.
Publicado: (2020) -
Whole-exome mutational landscape of neuroendocrine carcinomas of the gallbladder
por: Liu, Fatao, et al.
Publicado: (2021) -
Rac GTPase activating protein 1 promotes gallbladder cancer via binding DNA ligase 3 to reduce apoptosis
por: Bian, Rui, et al.
Publicado: (2021) -
Chloride intracellular channel 1 regulates the antineoplastic effects of metformin in gallbladder cancer cells
por: Liu, Yongchen, et al.
Publicado: (2017)